MCED
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Detection of Pancreatic Cancer Using a Methylation-Specific PCR-Based Multi-Cancer Early Detection Test
Context: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy often diagnosed at advanced stages due to the lack of early clinical symptoms. DNA methylation alterations arise early in PDAC tumorigenesis and may serve as promising biomarkers for blood-based cancer detection. Objective: To evaluate the performance of EPISEEK, a laboratory-developed blood-based multi-cancer early detection (MCED) assay, for detecting PDAC across disease stages.
Scientists were excited about a blood test for many cancers — but it failed a big trial. Here's what to know.
Scientists were excited about a blood test for many cancers — but it failed a big trial. Emerging tests promise to screen for many cancers at once, but one just failed in a big trial. Will these diagnostics deliver on their promise someday?
'Holy grail' blood test to help NHS diagnose different cancers fails in trial
'Holy grail' blood test to help NHS diagnose different cancers fails in trial NHS hopes dashed after trial of the first multi-cancer blood test it had hoped would revolutionise treatment - but scientists say all may not be lost Hopes that a “revolutionary” cancer blood test could soon be rolled out on the NHS have been dashed after a trial failed to achieve its main goal. The NHS had hoped to prove that the first multi-cancer blood test, which has been dubbed the “Holy Grail” for medical...